CytochromeP-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries
- 1 July 2002
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 283 (1) , F60-F67
- https://doi.org/10.1152/ajprenal.00265.2001
Abstract
20-Hydroxyeicosatetraenoic acid (20-HETE), a potent vasoconstrictor and mediator of the myogenic response, is a major arachidonic acid metabolite in the microvasculature of the rat kidney formed primarily by the cytochrome P -450 (CYP) 4A isoforms, CYP4A1, CYP4A2, and CYP4A3. We examined CYP4A isoform expression and 20-HETE synthesis in microdissected interlobar, arcuate, and interlobular arteries; mRNA for all CYP4A isoforms was identified by RT-PCR. Western blot analysis indicated that the levels of CYP4A2/4A3-immunoreactive protein increased with decreased arterial diameter, whereas those of CYP4A1-immunoreactive protein remained unchanged. 20-HETE synthesis was the highest in the interlobular arteries (17 ± 1.62 nmol · mg−1 · h−1) and, like CYP4A2/4A3-immunoreactive protein, decreased with increasing vessel diameter (4.5 ± 1.21, 2.65 ± 0.58, and 0.81 ± 0.14 nmol · mg−1 · h−1 in the arcuate, interlobar, and segmental arteries, respectively). 20-HETE synthesis in the renal artery and the abdominal aorta was undetectable. The observed decreased immunoreactivity of NADPH-cytochrome P -450 ( c ) oxidoreductase with increased arterial diameter provided a possible explanation for the decreased capacity to generate 20-HETE in the large arteries. The increase in CYP4A isoform expression and 20-HETE synthesis with decreasing diameter along the preglomerular arteries and the potent biological activity of 20-HETE underscore the significance of 20-HETE as a modulator of renal hemodynamics.Keywords
This publication has 36 references indexed in Scilit:
- P450 SUBFAMILY CYP2J AND THEIR ROLE IN THE BIOACTIVATION OF ARACHIDONIC ACID IN EXTRAHEPATIC TISSUES*Drug Metabolism Reviews, 1999
- Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20‐HETE which enhances L‐type Ca2+ currentThe Journal of Physiology, 1998
- The cytochrome P450 4 (CYP4) familyGeneral Pharmacology: The Vascular System, 1997
- Cytochrome P450 4A Expression and Arachidonic Acid Omega-Hydroxylation in the Kidney of the Spontaneously Hypertensive RatNephron, 1996
- Hepatic and renal cytochrome P-450s in spontaneously hypertensive ratsBiochimica et Biophysica Acta (BBA) - General Subjects, 1991
- Cloning and Characterization of a Novel Member of the Cytochrome P450 Subfamily IVA in Rat ProstateDNA and Cell Biology, 1990
- ω- and (ω − 1) -hydroxylation of arachidonic acid, lauric acid and prostaglandin A1 by multiple forms of cytochrome P-450 purified from rat hepatic microsomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- The Rat Clofibrate-InducibleCYP4ASubfamily II. cDNA Sequence of IVA3, Mapping of theCyp4aLocus to Mouse Chromosome 4, and Coordinate and Tissue-Specific Regulation of theCYP4AGenesDNA, 1989
- The Rat Clofibrate-InducibleCYP4AGene Subfamily I. Complete Intron and Exon Sequence of theCYP4A1andCYP4A2Genes, Unique Exon Organization, and Identification of a Conserved 19-bp Upstream ElementDNA, 1989
- Comparative aspects of the mammalian cytochrome P450 IV gene familyXenobiotica, 1989